Outcome measure | Day 0 | Day 30 | Day 90 |
---|---|---|---|
QOL: | |||
 Group A | 75.45 ± 6.59 | 83.20 ± 9.41a | 89.84 ± 11.74ab |
 Group B | 77.71 ± 8.69 | 87.58 ± 9.93a | 100.47 ± 11.97ab |
 P value# | 1.000 | 0.321 | < 0.001 |
MMT (UE): | |||
 Group A | 0.82 ± 0.90 | 2.16 ± 0.96a | 2.93 ± 0.88ab |
 Group B | 1.17 ± 0.86 | 2.42 ± 0.93a | 3.31 ± 0.90ab |
 P value# | 0.658 | 1.000 | 0.463 |
MMT (LE): | |||
 Group A | 1.25 ± 1.04 | 2.47 ± 1.01a | 3.36 ± 0.89ab |
 Group B | 1.42 ± 0.98 | 2.88 ± 0.83a | 3.90 ± 0.54ab |
 P value# | 1.000 | 0.241 | 0.030 |
NIHSS: | |||
 Group A | 12.53 ± 1.59 | 6.78 ± 2.11a | 4.07 ± 2.07ab |
 Group B | 11.95 ± 1.45 | 6.20 ± 2.00a | 2.96 ± 1.99ab |
 P value# | 1.000 | 1.000 | 0.035 |
MMSE: | |||
 Group A | 15.22 ± 4.45 | 22.00 ± 3.59a | 24.33 ± 2.93ab |
 Group B | 15.80 ± 4.10 | 22.15 ± 3.46a | 24.42 ± 2.81ab |
 P value# | 1.000 | 1.000 | 1.000 |
Ashworth: | |||
 Group A | 0.09 ± 0.29 | 0.56 ± 0.54a | 0.64 ± 0.62ab |
 Group B | 0.11 ± 0.31 | 0.33 ± 0.51a | 0.45 ± 0.57b |
 P value# | 1.000 | 0.181 | 0.793 |